Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany Marika PlöthnerDana RibbentropMartin Frank Review Open access 12 July 2016 Pages: 1461 - 1480
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments Martin SteinhoffMarc VocansonGregor Schäfer Review Open access 18 July 2016 Pages: 1481 - 1501
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review Sanjay KalraVikram SinghDinesh Nagrale Review Open access 16 July 2016 Pages: 1502 - 1518
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study Yuuichi SakuraiMadoka ShiinoSetsuo Hasegawa Original Research 18 July 2016 Pages: 1519 - 1535
Sulodexide in Patients with Chronic Venous Disease of the Lower Limbs: Clinical Efficacy and Impact on Quality of Life Nizar ElleuchHichem ZidiOn behalf of the CVD study investigators Original Research Open access 11 July 2016 Pages: 1536 - 1549
Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice Stefan PeringsGeorg StöcklOn behalf of the RESPONSIfVE study investigators Original Research Open access 18 July 2016 Pages: 1550 - 1564
Assessment of Factors Related to the Understanding of Education and Knowledge of Self-Care among Patients with Diabetes Mellitus: A Cross-Sectional Prospective Study Oguzhan Sıtkı DizdarOzen Oz GulCanan Ersoy Original Research 11 July 2016 Pages: 1565 - 1578
Impact of Warfarin on Atrial-Fibrillation Outcomes Related to Economic Consumption Patterns: Hospitalization, Cost, and Mortality may be Predictable and Modifiable at the Population Level Michael H. KimQiang CaiGary A. Puckrein Original Research 25 July 2016 Pages: 1579 - 1599
A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China Ming CuiChen Chen TuCan Chen Original Research 11 July 2016 Pages: 1600 - 1611
Long-term Safety and Efficacy of Latanoprostene Bunod 0.024% in Japanese Subjects with Open-Angle Glaucoma or Ocular Hypertension: The JUPITER Study Kazuhide KawaseJason L. VittitowFor the JUPITER Study Group Original Research Open access 25 July 2016 Pages: 1612 - 1627
Additive Intraocular Pressure Lowering Effects of the Rho Kinase Inhibitor, Ripasudil in Glaucoma Patients Not Able to Obtain Adequate Control After Other Maximal Tolerated Medical Therapy Shino SatoKazuyuki HirookaAkitaka Tsujikawa Original Research 20 July 2016 Pages: 1628 - 1634
Comparative Analysis of Length of Stay and Inpatient Costs for Orthopedic Surgery Patients Treated with IV Acetaminophen and IV Opioids vs. IV Opioids Alone for Post-Operative Pain Ryan N. HansenAn PhamGeorge J. Wan Original Research Open access 16 July 2016 Pages: 1635 - 1645
Erratum to: Comparative Analysis of Length of Stay and Inpatient Costs for Orthopedic Surgery Patients Treated with IV Acetaminophen and IV Opioids vs. IV Opioids Alone for Post-Operative Pain Ryan N. HansenAn PhamGeorge J. Wan Erratum Open access 25 August 2016 Pages: 1646 - 1648
Fentanyl Iontophoretic Transdermal System (IONSYS®) can be Safely used in the Hospital Environment with X-Rays, Computerized Tomography and Radiofrequency Identification Devices John LemkeEdmond SardarianiEugene R. Viscusi Original Research Open access 16 July 2016 Pages: 1649 - 1659
The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK Wrik GhoshRose WicksteadRuth Pulikottil-Jacob Original Research 25 July 2016 Pages: 1660 - 1676
Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT Andrew HughesDonal LandersJennifer Royle Erratum Open access 27 July 2016 Pages: 1677 - 1678
